Please turn JavaScript on
Dr. Malcolm Kendrick icon

Dr. Malcolm Kendrick

Specificfeeds gives you an easy way to subscribe to Dr. Malcolm Kendrick's news feed! Click on Follow below and we deliver the updates you want via email, phone or you can read them here on the website on your own news page.

You can also unsubscribe anytime painlessly. You can even combine feeds from Dr. Malcolm Kendrick with other site's feeds!

Title: Dr. Malcolm Kendrick | Scottish Doctor, author, speaker, sceptic

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.12 / day

Message History

In my book the Clot Thickens, and in other blogs and lectures, I have stated that LDL cannot get through the endothelium (lining of blood vessel walls) and into the artery wall behind. So, the idea of LDL leaking from the bloodstream and into the artery wall is nonsense.

Recently, however, people have been bombarding me with papers and AI generated essays, stating t...


Read full story

This weekend, Sat 30th – Sun 31st.

WE LOVE OUR HEART – This weekend sat 30th, Sun 31st May

Some of you may know of Mark Felstead and his tireless work to promote new ways to protect your heart, and keep lovely clean arteries where the blood flows fast and smooth.

This weekend there is an on-line meeting with several speakers/presentation and Q an...


Read full story

[Part two of a review on the National Institute for Health and Care Excellence (NICE). Which approved Wegovy (semaglutide) for use in preventing CV disease].

Stripping it down to basics, the key messages from the NICE report were:


Read full story

Lose weight, reduce the risk of CV disease – unless you are taking Wegovy?

[A tale of mystery and intrigue unfolds].

A lot of people have asked me about the weight loss drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 agonists) e.g. Wegovy (semaglutide), or Mounjaro (tirzepatide). What do I think of them, are they any goo...


Read full story